Hong M Moulton

This inventor holds 9 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Avi Biopharma, Inc., Sarepta Therapeutics, Inc., M.i.t.. Active years: 2008-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong M Moulton. Retrieved from https://idiyas.com/inventor/hong-m-moulton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 5)

% Patents Active = 55.6

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 191(Granted Patents)

Company Filing History:

Sarepta Therapeutics, Inc.

4. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2008-2022

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11236329 - Compound and method for treating myotonic dystrophy (2022-02-01),

2. 10905782 - Compositions for enhancing transport of molecules into cells (2021-02-02),

3. 10300149 - Compositions for enhancing transport of molecules into cells (2019-05-28),

4. 9572899 - Compositions for enhancing transport of molecules into cells (2017-02-21),

5. 8741863 - Compound and method for treating myotonic dystrophy (2014-06-03),

6. 8575126 - Conjugate constructs, delivery, and use for treatment of disease (2013-11-05),

7. 8357664 - Antisense antiviral compound and method for treating influenza viral infection (2013-01-22),

8. 8008469 - Antisense compound for inducing immunological tolerance (2011-08-30),

9. 7468418 - Compositions for enhancing transport of molecules into cells (2008-12-23),

As an AI assistant focusing on innovations, inventions, inventors, patent attorneys, assignees and patents, I can assist you with creating an article about inventor Hong M Moulton.

Title: Honoring the Innovative Mind of Hong M Moulton

Introduction: Hong M Moulton, a brilliant inventor based in Corvallis, Oregon, has made significant contributions to the field of molecular biology and genetics, with an impressive portfolio of 9 patents to his name.

Latest Patents: Among his recent patents is a groundbreaking compound and method for treating myotonic dystrophy. This invention involves an antisense compound designed to target specific genetic repeats in the dystrophia myotonica protein kinase mRNA, offering a promising approach for treating this debilitating condition.

Career Highlights: Hong M Moulton has showcased his expertise at prominent companies such as Avi Biopharma, Inc. and Sarepta Therapeutics, Inc. His work reflects a deep understanding of molecular mechanisms and a relentless pursuit of innovative solutions in the biotechnology sector.

Collaborations: Throughout his career, Hong M Moulton has collaborated with esteemed professionals in the field, including Patrick L Iversen and David A Stein. These partnerships have fostered a culture of innovation and teamwork, leading to the development of cutting-edge technologies.

Conclusion: In conclusion, Hong M Moulton stands as a beacon of innovation in the realm of molecular biology, with his patents and collaborations underscoring his commitment to advancing medical science. His inventive spirit and dedication to transformative research continue to inspire and shape the future of biotechnology.

If you need more information or assistance with other related topics like innovations, inventions, patent attorneys, assignees, and patents, feel free to reach out.

Profile summary based on public USPTO records.